Top Price Market
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Top Price Market

Investing

Biomarker Technologies for Cardiovascular Health

by August 6, 2024
August 6, 2024
Biomarker Technologies for Cardiovascular Health

Cardiex Limited (ASX:CDX) (the “Company”) is pleased to present its investor presentation.

June 2024 Quarterly Highlights

Record annual company revenues – $12.4m.

Initial Pulse units arrived in USA & Australia.Marketing and demand generation campaigns driving awareness and demand.New partnerships and pilot programs.Initial Pulse production run increased to 8,000 (previously 3,000). Pre-submission phase for OTC FDA-clearance for the Pulse. New patent awarded by USPTO for wearable PPG sensor technology.Nearing completion of our wearable sensor validation study.FDA submission for wearable technology anticipated Q1 25.

Financial Overview (Q4 ending 30 June 2024)

Revenue and other income for FY24 of $12.4m (FY23 – $6.0m)Q4 operating cash outflows of $2.8m, being a significant reduction to the Q3 normalized operating outflows of $3.4m, due to:Higher cash receipts of $0.9m in Q4 vs $0.7m in Q3, andFY23 R&D tax incentive of $0.7m.Cash resources and reserves ~ $6.5m, comprising:$0.5m cash; and$6.0m being funded under the Funding Commitment Agreement with C2 Ventures.Cash resources are believed to be sufficient to fund the Company’s growth initiatives, its operations, and to meet its business objectives.

Click here for the full ASX Release

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Assays up to 63g/t Gold and 3.2% Copper Highlight Immense Exploration Upside
next post
PEP11 Update

You may also like

Adam Rozencwajg: Uranium at Inflection Point, Will Get...

Tariff Fallout: GM’s Shift Cut in Oshawa Triggers...

Awalé Expands BBM Trend to Over 15km with...

Gareth Soloway: Gold’s Next Key Price Level, Silver...

Commissioning Proceeding to Plan as Boss Prepares for...

How to Invest in Molybdenum Stocks (Updated 2024)

Crypto Market Recap: CME Launches SOL Futures Contracts,...

Canada Nickel Receives Equity Investment from Samsung SDI

Trailbreaker Resources Extends Surficial Gold Signature at Golden...

Definitive Feasibility Study Confirms Strong Financial Returns, Rapid...

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Vance says India-Pakistan conflict ‘none of our business’ as Trump offers US...

    • Trump pushes tax hikes for wealthy as ‘big, beautiful bill’ deadline looms

    • US and other allies of Ukraine pile pressure on Putin, threatening fresh sanctions if he refuses 30-day truce

    • OpenAI’s Sam Altman thanks Sen John Fetterman for ‘normalizing hoodies’

    • Former Supreme Court Justice David Souter dead at 85

    Categories

    • Business (1,632)
    • Investing (4,781)
    • Politics (7,552)
    • Uncategorized (2)
    • World (6,137)
    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Disclaimer: toppricemarket.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 toppricemarket.com | All Rights Reserved


    Back To Top